# INTI (Inhibitor Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Inhibitor Therapeutics, Inc. reported $247K in total assets and a net loss of $3.19M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/INTI
- Markdown: https://convexityos.com/fundamentals/INTI.md
- SEC CIK: 0001042418
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001042418&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$3.22M | Operating profit |
| Net Income | FY 2025 | -$3.19M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.02 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $146K | Total debt: $14K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $1.70M | $1.76M | $1.38M | $6.2K | $4.9K | $185K | $1.21M | $2.63M | $2.23M | $2.64M |
| Total Operating Expenses | $3.43M | $3.66M | $3.40M | $658K | $325K | $1.06M | $2.75M | $4.56M | $5.12M | $7.02M |
| **Operating Income** | -$3.43M | -$3.66M | -$3.40M | -$658K | -$325K | -$1.06M | -$2.75M | -$4.56M | -$5.12M | -$7.02M |
| Interest Expense | -- | -- | -- | $23K | $15K | -- | -- | -- | -- | -- |
| Income Before Tax | -- | -- | -$3.03M | $12.16M | -$299K | -- | -- | -- | -- | -- |
| Income Tax Expense | -- | -- | -- | $55K | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$3.30M | -$3.34M | -$3.03M | $12.11M | -$299K | -$1.06M | -$2.73M | -$4.55M | -$5.10M | -$7.00M |
| Basic EPS | -$0.02 | -$0.02 | -$0.02 | $0.03 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
| **Diluted EPS** | -$0.02 | -$0.02 | -$0.02 | $0.03 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
| Basic Shares Outstanding | 172.5M | 172.3M | 172.0M | 366.2M | 376.2M | 371.9M | 370.4M | 369.8M | 366.6M | 288.8M |
| Diluted Shares Outstanding | 172.5M | 172.3M | 172.0M | 366.2M | 376.2M | 371.9M | 370.4M | 369.8M | 366.6M | 288.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $228K | $224K | $341K | $757K | $378K | $326K | $236K | $888K |
| Total Operating Expenses | $592K | $619K | $696K | $1.32M | $741K | $696K | $675K | $1.48M |
| **Operating Income** | -$592K | -$619K | -$696K | -$1.32M | -$741K | -$696K | -$675K | -$1.48M |
| **Net Income** | -$590K | -$614K | -$686K | -$1.30M | -$712K | -$660K | -$633K | -$1.42M |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 173.8M | 173.3M | 172.6M | -- | 172.6M | 172.6M | 172.3M | -- |
| Diluted Shares Outstanding | 173.8M | 173.3M | 172.6M | -- | 172.6M | 172.6M | 172.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.38M | $5.61M | $8.84M | $11.95M | $31K | $75K | $804K | $1.11M | $344K | $6.89M |
| **Cash & Short-Term Investments** | $2.38M | $5.61M | $8.84M | $11.95M | $31K | $75K | $804K | $1.11M | $344K | $6.89M |
| **Total Current Assets** | $2.45M | $5.69M | $8.95M | $11.98M | $59K | $107K | $846K | $1.15M | $656K | $7.20M |
| Other Non-Current Assets | -- | -- | -- | -- | $0 | $24K | $54K | $83K | $112K | $142K |
| **Total Non-Current Assets** | $64K | $0 | $0 | $0 | $0 | $24K | $54K | $83K | $112K | $142K |
| **Total Assets** | $2.51M | $5.69M | $8.95M | $11.98M | $59K | $132K | $900K | $1.23M | $768K | $7.34M |
| Accounts Payable | $52K | $16K | $34K | $145K | $280K | $269K | $316K | $385K | $535K | $298K |
| Other Current Liabilities | -- | -- | -- | -- | $53K | $25K | $14K | $216K | $67K | $10K |
| **Total Current Liabilities** | $766K | $710K | $665K | $679K | $680K | $425K | $431K | $701K | $601K | $308K |
| Long-Term Debt | $37K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $500K | -- | -- |
| **Total Non-Current Liabilities** | $3.04M | $3.00M | $3.00M | $3.00M | $3.00M | $3.07M | $3.00M | $500K | $0 | $0 |
| **Total Liabilities** | $3.80M | $3.71M | $3.67M | $3.68M | $3.68M | $3.49M | $3.43M | $1.20M | $601K | $308K |
| **Total Debt (incl. Leases)** | $99K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $17K | $17K | $17K | $17K | $38K | $37K | $37K | $37K | $37K | $35K |
| Retained Earnings | -$55.42M | -$52.12M | -$48.78M | -$45.75M | -$57.67M | -$57.17M | -$55.91M | -$52.98M | -$48.27M | -$43.17M |
| **Total Stockholders' Equity** | -$1.29M | $1.99M | $5.28M | $8.30M | -$3.62M | -$3.36M | -$2.53M | $32K | $167K | $7.03M |
| Total Equity | -$1.29M | $1.99M | $5.28M | $8.30M | -$3.62M | -$3.36M | -$2.53M | $32K | $167K | $7.03M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $146K | $516K | $1.29M | $2.38M | $2.98M | $3.74M | $4.32M | $5.61M |
| **Cash & Short-Term Investments** | $146K | $516K | $1.29M | $2.38M | $2.98M | $3.74M | $4.32M | $5.61M |
| **Total Current Assets** | $204K | $587K | $1.38M | $2.45M | $3.06M | $3.83M | $4.42M | $5.69M |
| **Total Non-Current Assets** | $43K | $50K | $57K | $64K | $71K | $78K | $84K | $0 |
| **Total Assets** | $247K | $637K | $1.43M | $2.51M | $3.14M | $3.91M | $4.51M | $5.69M |
| Accounts Payable | $221K | $139K | $320K | $52K | $20K | $106K | $37K | $16K |
| **Total Current Liabilities** | $383K | $175K | $382K | $766K | $88K | $140K | $95K | $710K |
| Long-Term Debt | $14K | $22K | $29K | $37K | $44K | $52K | $58K | -- |
| Deferred Revenue (Non-Current) | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| **Total Non-Current Liabilities** | $3.01M | $3.02M | $3.03M | $3.04M | $3.04M | $3.05M | $3.06M | $3.00M |
| **Total Liabilities** | $3.40M | $3.20M | $3.41M | $3.80M | $3.13M | $3.19M | $3.15M | $3.71M |
| **Total Debt (incl. Leases)** | $14K | $22K | $29K | $99K | $116K | $130K | $143K | -- |
| Common Stock | $17K | $17K | $17K | $17K | $17K | $17K | $17K | $17K |
| Retained Earnings | -$57.31M | -$56.72M | -$56.11M | -$55.42M | -$54.12M | -$53.41M | -$52.75M | -$52.12M |
| **Total Stockholders' Equity** | -$3.15M | -$2.56M | -$1.98M | -$1.29M | $3.5K | $716K | $1.35M | $1.99M |
| Total Equity | -$3.15M | -$2.56M | -$1.98M | -$1.29M | $3.5K | $716K | $1.35M | $1.99M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.30M | -$3.34M | -$3.03M | $12.11M | -$299K | -$1.06M | -$2.73M | -$4.55M | -$5.10M | -$7.00M |
| Stock-Based Compensation | $23K | $40K | $14K | -- | $38K | $229K | $270K | $543K | $1.87M | $3.56M |
| **Operating Cash Flow** | -$3.23M | -$3.23M | -$2.70M | $11.74M | -$220K | -$825K | -$2.71M | -$3.71M | -$2.91M | -$3.76M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.66M |
| Dividends Paid | -- | -- | -- | -- | -- | $0 | -$99K | -- | -- | -- |
| **Financing Cash Flow** | -- | -- | -$411K | $180K | $176K | $97K | $2.40M | $4.47M | -$3.63M | $10.04M |
| **Net Change in Cash** | -$3.23M | -$3.23M | -$3.11M | $11.92M | -$44K | -$729K | -$305K | $765K | -$6.54M | $6.28M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$590K | -$614K | -$686K | -$1.30M | -$712K | -$660K | -$633K | -$1.42M |
| Stock-Based Compensation | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Operating Cash Flow** | -$370K | -$775K | -$1.08M | -$601K | -$761K | -$584K | -$1.28M | -$771K |
| **Net Change in Cash** | -$370K | -$775K | -$1.08M | -$601K | -$761K | -$584K | -$1.28M | -$771K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -168.2% | -57.3% | 145.9% | -- | -- | -- | -14065.2% | -3062.6% | -99.6% |
| Return on Assets (ROA) | -131.4% | -58.6% | -33.8% | 101.1% | -508.0% | -802.9% | -303.7% | -369.0% | -664.2% | -95.4% |
| Current Ratio | 3.19x | 8.02x | 13.45x | 17.64x | 0.09x | 0.25x | 1.96x | 1.64x | 1.09x | 23.36x |
| Quick Ratio | 3.10x | 7.90x | 13.29x | 17.61x | 0.05x | 0.18x | 1.86x | 1.58x | 0.57x | 22.35x |
| **Net Income Growth (YoY)** | -- | -- | -125.0% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -166.7% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -123.0% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -- | -201.9% | -- |
| 10Y Net Income / Share Growth | -- | -- | -- | +142.1% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -99241.7% | -481.5% | -243.1% | -168.2% |
| Return on Assets (ROA) | -1288.1% | -519.1% | -234.0% | -131.4% | -109.3% | -88.2% | -73.0% | -58.6% |
| Current Ratio | 0.53x | 3.36x | 3.60x | 3.19x | 35.00x | 27.36x | 46.68x | 8.02x |
| Quick Ratio | 0.38x | 2.95x | 3.38x | 3.10x | 34.01x | 26.71x | 45.63x | 7.90x |
| Debt to Equity | -- | -- | -- | -- | 33.54x | 0.18x | 0.11x | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
